Annual Grant Award Dollars
Investigator | Title | Sponsor | ID | Dates | Amount |
Burns C Blaxall, PHD | Small molecule targeting of MLK3 for heart failure | National Institutes of Health (NIH) | R01HL129772 | 12/1/2017 - 11/30/2018 | $7,800 |
Burns C Blaxall, PHD Prasad Devarajan Katherine Yutzey |
Targeting pathologic G-protein signaling in cardiac and kidney fibrosis | National Institutes of Health (NIH) | R01HL133695 | 8/1/2018 - 7/31/2019 | $305,255 |
Justin G Boyer, PHD | The role of Erk1/2 signaling in satellite cells | Muscular Dystrophy Association | MDA603521 | 2/1/2019 - 1/31/2020 | $70,000 |
Matthew J Brody, PHD | The role of palmitoylation in cardiac signal transduction and disease pathogenesis | National Heart, Lung & Blood Institute (National Institutes of Health (NIH)) | K99HL136695 | 1/1/2019 - 12/31/2019 | $129,060 |
Michael J Bround, PHD | The Role of Micu2 in Ischemia Reperfusion Injury and Cardiomyocyte Biology | American Heart Association - National (American Heart Association - National) | 18POST33960216 | 7/1/2018 - 6/30/2019 | $51,844 |
Jacob Gafranek | Nr2f1a suppresses bulbous arteriosus identity in the zebrafish atrium | National Institutes of Health (NIH) | F31HL147399 | 4/11/2019 - 4/10/2020 | $40,182 |
Kelly M Grimes, PHD | Defining the mechanisms whereby MEK1/2 and ERK1/2 signal | National Institutes of Health (NIH) | F32HL138747 | 7/24/2018 - 7/23/2019 | $61,174 |
Andrew Holowiecki, PHD | PBX4 ensures proper OFT development by regulating SHFP migration and proliferation during cardiogenesis | American Heart Association - National | 18POST34050034 | 7/1/2018 - 6/30/2019 | $52,216 |
Luis A Hortells Garcia, PHD | Postnatal regulation of extracellular matrix and cardiomyocyte cell proliferation by Postn+ cardiac fibroblasts | American Heart Association - National | 19POST34380004 | 1/1/2019 - 12/31/2019 | $52,216 |
Jiuzhou Huo | The role of MCUb in ischemia reperfusion injury | American Heart Association - National | 19PRE34380906 | 1/1/2019 - 12/31/2019 | $26,844 |
Jason Karch, PHD | Identification of Novel Regulators of Necrosis in the Ischemic Heart | American Heart Association - National | 17SDG33661152 | 7/1/2018 - 6/30/2019 | $77,000 |
Bryan Maliken | Cardiovascular Impact of Gata4 Loss in the c-Kit Lineage | National Institutes of Health (NIH) | F30HL137239 | 9/30/2018 - 9/29/2019 | $47,017 |
Qinghang Meng, PHD | The role of EMC3 in cardiovascular disease and development | American Heart Association - National | 17POST33670035 | 7/1/2018 - 6/30/2019 | $54,316 |
Douglas P Millay, PHD | Deciphering mechanisms of myoblast fusion | National Institutes of Health (NIH) | R01AR068286 | 7/1/2018 - 6/30/2019 | $343,200 |
Douglas P Millay, PHD | Molecular Dissection of Cell Fusion | The Pew Charitable Trusts | 28646 | 8/1/2017 - 7/31/2019 | $60,000 |
Douglas P Millay, PHD | Role of skeletal muscle stem cell fusion and fibrosis during aging | National Institutes of Health (NIH) | R01AG059605 | 7/15/2018 - 3/31/2020 | $699,600 |
Jeffery D Molkentin, PHD | Understanding Cardiovascular Disease Mechanisms | National Institutes of Health (NIH) | T32HL125204 | 12/1/2017 - 11/30/2019 | $340,316 |
Jeffery D Molkentin, PHD | Thrombospondin 4 regulates adaptive ER stress response | National Institutes of Health (NIH) | R01HL105924 | 1/1/2018 - 12/31/2018 | $8,537 |
Jeffery D Molkentin, PHD | Molecular examination of mitochondrial calcium control | National Institutes of Health (NIH) | R01HL132831 | 4/1/2018 - 3/31/2020 | $760,641 |
Jeffery D Molkentin, PHD | Paracrine hypothesis underlying cardiac stem cell therapy | Temple University School of Medicine (National Institutes of Health (NIH)) | 258578 | 4/1/2018 - 3/31/2019 | $375,312 |
Jeffery D Molkentin, PHD | Targeting Mitochondria to Treat Heart Disease | Foundation LeDucq | Molkentin_Fondation | 10/1/2018 - 9/30/2019 | $150,000 |
Jeffery D Molkentin, PHD | In vivo role of the fibroblast in muscular dystrophy | National Institutes of Health (NIH) | R01AR071301 | 4/1/2019 - 3/31/2020 | $349,800 |
Jeffery D Molkentin, PHD | Molecular pathways controlling cardiac gene expression | National Institutes of Health (NIH) | 2R01HL060562-21 | 7/1/2018 - 6/30/2019 | $397,500 |
Jeffery D Molkentin, PHD | Finding the combinatorial code for cardiomyocyte proliferation | American Heart Association - National | 19MERIT34370048 | 1/1/2019 - 12/31/2019 | $200,000 |
Jeffery D Molkentin, PHD | Thrombospondin 4 regulates adaptive ER stress response | National Institutes of Health (NIH) | R01HL105924 | 2/15/2019 - 1/31/2020 | $418,682 |
Yuntao Song | Epigenetic repression of retinoid acid responsive genes is required for cardiac outflow tract formation | American Heart Association - National | 17PRE33661080 | 7/1/2018 - 6/30/2019 | $26,844 |
Ronald J Vagnozzi, PHD | Genetic Modulation of Macrophage-Fibroblast Crosstalk to Enhance Tissue Healing after Myocardial Infarction | American Heart Association - National | 19CDA34670044 | 4/1/2019 - 3/31/2020 | $77,000 |
Nivedhitha Velayutham | Role of Btg1/2 anti-proliferative genes in postnatal cardiomyocyte cell cycle arrest | American Heart Association - National | 19PRE34380046 | 1/1/2019 - 12/31/2019 | $26,844 |
Joshua Waxman, PHD | Molecular mechanisms of atrial development and regeneration | National Institutes of Health (NIH) | R01HL137766 | 7/1/2018 - 6/30/2019 | $397,500 |
Joshua Waxman, PHD | Retinoic acid-dependent epigenetic and transcriptional mechanisms controlling heart development | National Institutes of Health (NIH) | R01HL141186 | 2/1/2019 - 1/31/2020 | $397,500 |
Katherine E Yutzey, PHD | Regulatory mechanisms of adult cardiomyocyte proliferation | National Institutes of Health (NIH) | R01HL135848 | 12/1/2017 - 11/30/2019 | $442,254 |
Katherine E Yutzey, PHD | Cincinnati Children's SURF program | American Heart Association - National | 18UFEL33930019 | 4/1/2019 - 3/31/2020 | $20,000 |
Katherine E Yutzey, PHD | Mechanisms of Congenital Heart Valve Disease | National Institutes of Health (NIH) | 1R01HL143881 | 7/1/2018 - 4/30/2020 | $967,820 |
Katherine E Yutzey, PHD Jeffery D Molkentin, PHD |
Cardiac fibroblasts in postnatal development and adult injury response | National Institutes of Health (NIH) | R01HL142217-01A1 | 7/1/2018 - 6/30/2019 | $708,904 |
Current Year Direct | $8,143,178 |